Yi Gang1, Hanney Gonna1,2, Giulia Domenichini1, Michael Sampson1, Niloufar Aryan1, Mark Norman1,3, Elijah R Behr1, Zia Zuberi1,4, Paramdeep Dhillon1,5, Mark M Gallagher6,7,8. 1. Cardiology Clinical Academic Group, St. George's University Hospitals NHS Foundation Trust, St. George's, University of London, London, UK. 2. National Heart & Lung Institute, Imperial College London, London, UK. 3. Frimley Park Hospital, Frimley, UK. 4. The Royal Surrey County Hospital, Guildford, UK. 5. St. Peter's Hospital, Chertsey, UK. 6. Cardiology Clinical Academic Group, St. George's University Hospitals NHS Foundation Trust, St. George's, University of London, London, UK. mark_m_gallagher@hotmail.com. 7. St. Peter's Hospital, Chertsey, UK. mark_m_gallagher@hotmail.com. 8. Department of Cardiology, St. George's Hospital, Blackshaw Road, London, SW17 0QT, UK. mark_m_gallagher@hotmail.com.
Abstract
PURPOSE: The purpose of this study is to establish the role of Achieve Mapping Catheter in cryoablation for paroxysmal atrial fibrillation (PAF) in a randomized trial. METHODS: A total of 102 patients undergoing their first ablation for PAF were randomized at 2:1 to an Achieve- or Lasso-guided procedure. Study patients were systematically followed up for 12 months with Holter monitoring. Primary study endpoint was acute procedure success. Secondary endpoint was clinical outcomes assessed by AF free at 6 and 12 months after the procedure. RESULTS: Of 102 participants, 99 % of acute procedure success was achieved. Significantly shorter procedure duration with the Achieve-guided group than with the Lasso-guided group (118 ± 18 vs. 129 ± 21 min, p < 0.05) was observed as was the duration of fluoroscopy (17 ± 5 vs. 20 ± 7 min, p < 0.05) by subgroup analysis focused on procedures performed by experienced operators. In the whole study patients, procedure and fluoroscopic durations were similar in the Achieve- (n = 68) and Lasso-guided groups (n = 34). Transient phrenic nerve weakening was equally prevalent with the Achieve and Lasso. No association was found between clinical outcomes and the mapping catheter used. The use of second-generation cryoballoon (n = 68) reduced procedure time significantly compared to the first-generation balloon (n = 34); more patients were free of AF in the former than the latter group during follow-up. CONCLUSIONS: The use of the Achieve Mapping Catheter can reduce procedure and fluoroscopic durations compared with Lasso catheters in cryoablation for PAF after operators gained sufficient experience. The type of mapping catheter used does not affect procedure efficiency and safety by models of cryoballoon.
RCT Entities:
PURPOSE: The purpose of this study is to establish the role of Achieve Mapping Catheter in cryoablation for paroxysmal atrial fibrillation (PAF) in a randomized trial. METHODS: A total of 102 patients undergoing their first ablation for PAF were randomized at 2:1 to an Achieve- or Lasso-guided procedure. Study patients were systematically followed up for 12 months with Holter monitoring. Primary study endpoint was acute procedure success. Secondary endpoint was clinical outcomes assessed by AF free at 6 and 12 months after the procedure. RESULTS: Of 102 participants, 99 % of acute procedure success was achieved. Significantly shorter procedure duration with the Achieve-guided group than with the Lasso-guided group (118 ± 18 vs. 129 ± 21 min, p < 0.05) was observed as was the duration of fluoroscopy (17 ± 5 vs. 20 ± 7 min, p < 0.05) by subgroup analysis focused on procedures performed by experienced operators. In the whole study patients, procedure and fluoroscopic durations were similar in the Achieve- (n = 68) and Lasso-guided groups (n = 34). Transient phrenic nerve weakening was equally prevalent with the Achieve and Lasso. No association was found between clinical outcomes and the mapping catheter used. The use of second-generation cryoballoon (n = 68) reduced procedure time significantly compared to the first-generation balloon (n = 34); more patients were free of AF in the former than the latter group during follow-up. CONCLUSIONS: The use of the Achieve Mapping Catheter can reduce procedure and fluoroscopic durations compared with Lasso catheters in cryoablation for PAF after operators gained sufficient experience. The type of mapping catheter used does not affect procedure efficiency and safety by models of cryoballoon.
Authors: Jason G Andrade; Paul Khairy; Laurent Macle; Doug L Packer; John W Lehmann; Richard G Holcomb; Jeremy N Ruskin; Marc Dubuc Journal: Circ Arrhythm Electrophysiol Date: 2014-01-19
Authors: J Brian DeVille; J Thomas Svinarich; Dan Dan; Andrew Wickliffe; Charan Kantipudi; Hae W Lim; Lisa Plummer; James Baker; Marcin Kowalski; Hassan Baydoun; Mark Jenkins; Peter Chang-Sing Journal: J Invasive Cardiol Date: 2014-06 Impact factor: 2.022
Authors: Michael Kühne; Sven Knecht; David Altmann; Peter Ammann; Beat Schaer; Stefan Osswald; Christian Sticherling Journal: Heart Rhythm Date: 2012-10-04 Impact factor: 6.343
Authors: Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Melanie Gunawardene; Britta Schulte-Hahn; Verena Urban; Frank Bode; Bernd Nowak; Julian K R Chun Journal: J Cardiovasc Electrophysiol Date: 2013-02-11
Authors: Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin Journal: J Am Coll Cardiol Date: 2013-03-21 Impact factor: 24.094
Authors: Luigi Sciarra; Saverio Iacopino; Zefferino Palamà; Ermenegildo De Ruvo; Pasquale Filannino; Alessio Borrelli; Paolo Artale; Alberto Caragliano; Antonio Scarà; Paolo Golia; Lucia De Luca; Domenico Grieco; Marco Rebecchi; Stefano Favale; Leonardo Calò Journal: Indian Pacing Electrophysiol J Date: 2018-02-22